CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205473709
- Phone
- 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | Patel Snehal CEO and CFO | Purchase | +174,825 | $14.30 | $2.5M | 5,525,602 |
| 2024-04-01 | Patel Snehal CEO and CFO | Purchase | +3,000 | $19.08 | $57K | 5,350,777 |
| 2024-03-22 | Patel Snehal CEO and CFO | Purchase | +2,500 | $19.98 | $50K | 5,347,777 |
| 2024-03-20 | Patel Snehal CEO and CFO | Purchase | +1,500 | $17.68 | $27K | 5,345,277 |
| 2024-03-05 | Patel Snehal CEO and CFO | Purchase | +3,500 | $12.49 | $44K | 5,343,777 |
| 2024-03-05 | Patel Snehal CEO and CFO | Purchase | +30,500 | $12.49 | $381K | 5,343,777 |
| 2024-03-04 | Patel Snehal CEO and CFO | Purchase | +4,100 | $13.03 | $53K | 5,340,277 |
| 2024-02-16 | Patel Snehal CEO and CFO | Purchase | +10,800 | $11.16 | $121K | 5,336,177 |
| 2024-02-15 | Patel Snehal CEO and CFO | Purchase | +12,700 | $11.07 | $141K | 5,325,377 |
| 2023-11-10 | Patel Snehal CEO and CFO | Purchase | +5,000 | $10.17 | $51K | 5,312,677 |
| 2023-11-03 | Patel Snehal CEO and CFO | Purchase | +3,500 | $9.11 | $32K | 5,307,677 |
| 2023-10-27 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +500 | $8.57 | $4K | 260,348 |
| 2023-10-26 | Patel Snehal CEO and CFO | Purchase | +2,500 | $7.97 | $20K | 5,304,177 |
| 2023-10-25 | Patel Snehal CEO and CFO | Purchase | +2,500 | $7.91 | $20K | 5,301,677 |
| 2023-10-10 | Patel Snehal CEO and CFO | Purchase | +1,000 | $9.07 | $9K | 5,299,177 |
| 2023-10-04 | Patel Snehal CEO and CFO | Purchase | +2,000 | $8.63 | $17K | 5,298,177 |
| 2023-09-26 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +600 | $8.71 | $5K | 259,848 |
| 2023-09-19 | Patel Snehal CEO and CFO | Purchase | +4,000 | $8.95 | $36K | 5,296,177 |
| 2023-09-11 | Patel Snehal CEO and CFO | Purchase | +1,000 | $9.48 | $9K | 5,292,177 |
| 2023-08-22 | Patel Snehal CEO and CFO | Purchase | +1,000 | $9.97 | $10K | 5,291,177 |
Page 3 of 10 · 190 trades